Oportun Financial Corp
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
How The Oportun Financial (OPRT) Investment Story Is Shifting With Price Targets And Risk Views
Analysts have trimmed Oportun Financial’s fair value estimate from US$8.08 to US$7.92 per share, a small reset that still matters if you are watching the stock closely. Supportive views see this US$0.16 move as fine tuning rather than a reset of the story, while more cautious voices point to slightly less room between target and current price levels. Read on to see how you can track these shifting signals and keep up with the evolving narrative around Oportun Financial. Analyst Price Targets...
Congressional Trades in $OPRT
No disclosed congressional trades found in $OPRT.
Insider Trades (Form 4)
Schueller Joseph Andrew
Layton Kathleen I.
Rowles Sean A
Scheirman Scott
WILCOX WARREN
Miramontes Louis
Minetti Carlos
Daswani Mohit
Key People
Layton Kathleen I
Chief Legal Officer
Rowles Sean A
Chief Risk Officer
Schueller Joseph Andrew
SVP-Controller, CAO
Scheirman Scott
Director
WILCOX WARREN
Director
Daswani Mohit
Director
Miramontes Louis
Director
Lee Ginny
Director
Tambor Richard N
Director
Minetti Carlos
Director
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro